Background: Clinical trials process, crucial in the healthcare sector, is getting more and more costly, difficult to manage, with lots of players involved and more regulation coming regarding data. This is why there is a need to evolve this process towards interoperability, more secure, more attractive to get funding, and faster to reduce cost. Blockchain is a technology that can provide all of these needs, in a situation with enough maturity being able to develop system that can be applied in the market. Aims: Investigate on how blockchain technology can improve clinical trial process and see what values can bring to the process.
Methods: Applying a descriptive research strategy and a case study with process mapping to understand the clinical trial process. Doing a thematic analysis with an inductive approach from qualitative data using semi-structured interviews, focus group interviews, observations and academic research papers from the healthcare professionals and blockchain experts.
Findings: The best way that blockchain technology can help the clinical trial process and improve it is being a disruptive innovation and what is related therein. Mostly to create a new market that can incentive more clinical trials funding and have a better use of the data gathered in the trials.
Conclusion: The technology is ready to be applied. There are already solutions trying to improve the process. The main problem is that clinical trial process is so complex and requires so many developments, that there is a lot of work to be done before a solution can be accepted by different stakeholders, with all the regulations needed.
|Educations||MSc in Business Administration and Innovation in Health Care, (Graduate Programme) Final Thesis|
|Number of pages||157|